BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shi L, Shang X, Nie K, Lin Z, Zheng M, Wang M, Yuan H, Zhu Z. Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma. J Clin Pathol 2021;74:504-12. [PMID: 33004423 DOI: 10.1136/jclinpath-2020-206979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Cabrera-Galván JJ, Araujo E, de Mirecki-Garrido M, Pérez-Rodríguez D, Guerra B, Aranda-Tavío H, Guerra-Rodríguez M, Brito-Casillas Y, Melián C, Martínez-Martín MS, Fernández-Pérez L, Recio C. SOCS2 protects against chemical-induced hepatocellular carcinoma progression by modulating inflammation and cell proliferation in the liver. Biomed Pharmacother 2023;157:114060. [PMID: 36455458 DOI: 10.1016/j.biopha.2022.114060] [Reference Citation Analysis]
2 Zhang Y, Xie Y, Huang X, Zhang L, Shu K. Screening of Hub Genes in Hepatocellular Carcinoma Based on Network Analysis and Machine Learning. Comput Math Methods Med 2022;2022:7300788. [PMID: 36479313 DOI: 10.1155/2022/7300788] [Reference Citation Analysis]
3 Chen L, Lin Y, Liu G, Xu R, Hu Y, Xie J, Yu H. Clinical Value for Diagnosis and Prognosis of Signal Sequence Receptor 1 (SSR1) and Its Potential Mechanism in Hepatocellular Carcinoma: A Comprehensive Study Based on High-Throughput Data Analysis. Int J Gen Med 2021;14:7435-51. [PMID: 34744454 DOI: 10.2147/IJGM.S336725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Feng R, Li J, Xuan W, Liu H, Cheng D, Wang G. An Autophagy-Related Gene-Based Prognostic Risk Signature for Hepatocellular Carcinoma: Construction and Validation. Comput Math Methods Med 2021;2021:5770228. [PMID: 34691238 DOI: 10.1155/2021/5770228] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
5 Gao X, Zhao C, Zhang N, Cui X, Ren Y, Su C, Wu S, Yao Z, Yang J. Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients. BMC Cancer 2021;21:786. [PMID: 34238242 DOI: 10.1186/s12885-021-08442-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ren X, Li A, Ying E, Fang J, Li M, Yu J. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression. Bioengineered 2021;12:1530-42. [PMID: 33934686 DOI: 10.1080/21655979.2021.1918507] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Zhou Y, Zhang L, Song S, Xu L, Yan Y, Wu H, Tong X, Yan H. Elevated GAS2L3 Expression Correlates With Poor Prognosis in Patients With Glioma: A Study Based on Bioinformatics and Immunohistochemical Analysis. Front Genet 2021;12:649270. [PMID: 33859674 DOI: 10.3389/fgene.2021.649270] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]